Published: Fri, November 16, 2018
Medical | By Vicki Mclaughlin

Blood Pressure Recall: Medication Recalled By FDA For Cancer Risk

Blood Pressure Recall: Medication Recalled By FDA For Cancer Risk

NDEA is found naturally in certain foods, drinking water, air pollution, and industrial processes, and it may cause cancer, according to the International Agency for Research on Cancer.

FDA recall on Losartan, a popular blood pressure medication. They come in 1000-count plastic bottles labeled NDC 0781-5207-10 with a lot number of JB8912.

However, it's a bit more surprising because this type of thing had happened earlier year also when the same contamination was found in some blood pressure medicines and at that time more than 55 medications were recalled.

The US FDA has said that another medicine for the heart is getting recalled in a voluntary manner.

According to the FDA, Losartan Potassium-Hydrochlorothiazide Tablets, USP are indicated for the treatment of hypertension.

Rebel Wilson: Actress loses bid to reclaim record defamation payout
But lawyer for Bauer Media David Jackson QC said that point was based on a "misconception of the appropriate tests". A court awarded her a A$4.7m (£2.6m; $3.5m) payout past year , but that sum was reduced to A$600,000 on appeal.

Amy Schumer Hospitalized For Pregnancy Nausea & Cancels Show: Is She OK?
In the photo, Schumer looks to be wiped and in need of the break, though she promised to be "out there as soon as I'm better". As you may remember, earlier this month, Amy confessed that pregnancy has been really tough on her.

Agra woman bleeds to death after gruesome monkey attack
Some local organisations were calling for monkeys to be sterilised and excluded from wildlife protection legislation, he said. She was later found with severe injuries and transported to hospital, where she died.

"To date, Sandoz Inc. has not received any reports of adverse events related to this lot", the company said. It can be used alone or with other antihypertensive medications. None of the recalled tablets were distributed before October 8.

This is the third blood pressure medication to face recall as of late. In total, the recall encompasses less than 1% of the national losartan drug products.

Sandoz notifying its distributors by letter via overnight mail and patients by this public notification.

Sandoz is urging patients that take the affected medication to speak to their pharmacist or physician about alternative treatment, but they should continue to take the medication as the risk is higher if treatment is stopped abruptly without an alternate medication used.

This recall is being made with the knowledge of the Food and Drug Administration.

Like this: